KR890004690A - 당뇨병의 치료를 위한 베자피브레이드의 용도 - Google Patents
당뇨병의 치료를 위한 베자피브레이드의 용도 Download PDFInfo
- Publication number
- KR890004690A KR890004690A KR1019880011350A KR880011350A KR890004690A KR 890004690 A KR890004690 A KR 890004690A KR 1019880011350 A KR1019880011350 A KR 1019880011350A KR 880011350 A KR880011350 A KR 880011350A KR 890004690 A KR890004690 A KR 890004690A
- Authority
- KR
- South Korea
- Prior art keywords
- bezafibrate
- diabetes
- treatment
- bezafibraid
- release agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims 3
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 claims 4
- 229960000516 bezafibrate Drugs 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000023597 hemostasis Effects 0.000 claims 2
- 230000003914 insulin secretion Effects 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000010030 glucose lowering effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873729209 DE3729209A1 (de) | 1987-09-01 | 1987-09-01 | Verwendung von bezafibrat zur behandlung von diabetes |
| DE3729209.9 | 1987-09-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR890004690A true KR890004690A (ko) | 1989-05-09 |
Family
ID=6334986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880011350A Withdrawn KR890004690A (ko) | 1987-09-01 | 1988-09-01 | 당뇨병의 치료를 위한 베자피브레이드의 용도 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5304575A (OSRAM) |
| EP (1) | EP0305890B1 (OSRAM) |
| JP (1) | JP2647918B2 (OSRAM) |
| KR (1) | KR890004690A (OSRAM) |
| AT (1) | ATE95694T1 (OSRAM) |
| AU (1) | AU610228B2 (OSRAM) |
| CA (1) | CA1323575C (OSRAM) |
| DE (2) | DE3729209A1 (OSRAM) |
| DK (1) | DK472688A (OSRAM) |
| ES (1) | ES2059457T3 (OSRAM) |
| HU (1) | HU200687B (OSRAM) |
| IE (1) | IE62189B1 (OSRAM) |
| IL (1) | IL87566A0 (OSRAM) |
| PH (1) | PH24568A (OSRAM) |
| PT (1) | PT88383B (OSRAM) |
| ZA (1) | ZA886459B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| WO1998005331A2 (en) * | 1996-08-02 | 1998-02-12 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| AU8588798A (en) * | 1997-07-25 | 1999-02-16 | Institut Pasteur | Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor |
| FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
| AU2001236457A1 (en) | 2000-01-13 | 2001-07-24 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| JP4417113B2 (ja) | 2002-02-20 | 2010-02-17 | エミスフェアー・テクノロジーズ・インク | Ｇｌｐ−１分子の投与方法 |
| US7264813B2 (en) * | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| US20060286129A1 (en) * | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| JP4901218B2 (ja) * | 2004-02-09 | 2012-03-21 | あすか製薬株式会社 | 併用医薬 |
| FR2898894B1 (fr) * | 2006-03-24 | 2008-06-06 | Genfit Sa | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations |
| US10098860B2 (en) * | 2016-07-20 | 2018-10-16 | Cipla Limited | Bezafibrate for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2149070C3 (de) * | 1971-10-01 | 1978-03-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel |
| JPS56145261A (en) * | 1980-04-10 | 1981-11-11 | Kaken Pharmaceut Co Ltd | Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient |
-
1987
- 1987-09-01 DE DE19873729209 patent/DE3729209A1/de active Granted
-
1988
- 1988-08-18 IE IE252988A patent/IE62189B1/en not_active IP Right Cessation
- 1988-08-24 DK DK472688A patent/DK472688A/da not_active Application Discontinuation
- 1988-08-25 AT AT88113831T patent/ATE95694T1/de not_active IP Right Cessation
- 1988-08-25 IL IL87566A patent/IL87566A0/xx unknown
- 1988-08-25 HU HU884456A patent/HU200687B/hu not_active IP Right Cessation
- 1988-08-25 DE DE88113831T patent/DE3884895D1/de not_active Expired - Fee Related
- 1988-08-25 EP EP88113831A patent/EP0305890B1/de not_active Expired - Lifetime
- 1988-08-25 ES ES88113831T patent/ES2059457T3/es not_active Expired - Lifetime
- 1988-08-26 PH PH37464A patent/PH24568A/en unknown
- 1988-08-26 AU AU21586/88A patent/AU610228B2/en not_active Ceased
- 1988-08-31 ZA ZA886459A patent/ZA886459B/xx unknown
- 1988-08-31 CA CA000576196A patent/CA1323575C/en not_active Expired - Fee Related
- 1988-08-31 PT PT88383A patent/PT88383B/pt not_active IP Right Cessation
- 1988-09-01 KR KR1019880011350A patent/KR890004690A/ko not_active Withdrawn
- 1988-09-01 JP JP63216469A patent/JP2647918B2/ja not_active Expired - Lifetime
-
1992
- 1992-12-17 US US07/993,525 patent/US5304575A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2059457T3 (es) | 1994-11-16 |
| EP0305890B1 (de) | 1993-10-13 |
| DE3729209C2 (OSRAM) | 1989-08-03 |
| IE62189B1 (en) | 1994-12-28 |
| IE882529L (en) | 1989-03-01 |
| PT88383B (pt) | 1992-10-30 |
| CA1323575C (en) | 1993-10-26 |
| DK472688D0 (da) | 1988-08-24 |
| DE3884895D1 (de) | 1993-11-18 |
| EP0305890A3 (en) | 1990-08-22 |
| JP2647918B2 (ja) | 1997-08-27 |
| JPS6471813A (en) | 1989-03-16 |
| EP0305890A2 (de) | 1989-03-08 |
| AU610228B2 (en) | 1991-05-16 |
| IL87566A0 (en) | 1989-01-31 |
| PH24568A (en) | 1990-08-03 |
| ZA886459B (en) | 1989-05-30 |
| DK472688A (da) | 1989-03-02 |
| HU200687B (en) | 1990-08-28 |
| ATE95694T1 (de) | 1993-10-15 |
| AU2158688A (en) | 1989-05-25 |
| US5304575A (en) | 1994-04-19 |
| HUT47427A (en) | 1989-03-28 |
| PT88383A (pt) | 1989-07-31 |
| DE3729209A1 (de) | 1989-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT913156E (pt) | Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia | |
| KR890004690A (ko) | 당뇨병의 치료를 위한 베자피브레이드의 용도 | |
| DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| DE3587941D1 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
| ES2170813T3 (es) | Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina. | |
| KR970704440A (ko) | 당뇨병 타입 ⅱ의 치료용 약물에의 케토코나졸 및 관련 물질의 용도(use of ketoconazole and related substances in medicaments for treatment of type ⅱ diabetes) | |
| ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
| KR950007848A (ko) | (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법 | |
| KR940005283A (ko) | 활성 성분으로 글리센틴을 함유하는 약제 | |
| KR910009267A (ko) | 우울증의 치료방법 | |
| KR930019224A (ko) | 유산 위험 치료제 | |
| RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
| KR960701657A (ko) | 피부 상처 치료용 인자 XIII (Factor XIII for treatment of skin wounds) | |
| Duhault et al. | The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats | |
| KR880002535A (ko) | 약제로서의 15-데옥시스퍼구알린의 용도 | |
| KR910002456A (ko) | 당뇨병 치료용 제약 조성물 | |
| KR910021244A (ko) | 당뇨병성 괴저 치료제 | |
| RU2332990C1 (ru) | Способ лечения трофических язв у больных сахарным диабетом | |
| DE3650368D1 (de) | Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf. | |
| KR880000094A (ko) | 위염치료제 | |
| KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
| KR930702016A (ko) | 골다공증 치료제 | |
| KR900017592A (ko) | Tnf의 부작용을 감소시키기 위한 용도 및 약제 | |
| RU94010369A (ru) | Способ получения производных инсулина | |
| KR900701311A (ko) | 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19880901 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19960406 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19960731 Patent event code: PE09021S01D |